A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma

Clinical trial NCT00226980 · COMPLETED

Trial details

NCT number: NCT00226980
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2002-10-01
Primary completion: 2005-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.